Blood Res 2018; 53(4):
Published online December 31, 2018
https://doi.org/10.5045/br.2018.53.4.320
© The Korean Society of Hematology
1Department of Hematology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran.
2Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran, Iran.
3Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Tehran, Iran.
4Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran.
5Comprehensive Cancer Research Center, Mazandaran University of Medical Science, Sari, Iran.
Correspondence to : Correspondence to Saeid Kaviani, M.D. Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran, P.O.Box: 14115-331, kavianis@modares.a.ir
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recent studies have devoted much attention to non-protein-coding transcripts in relation to a wide range of malignancies.
Altered expression of
Keywords
Blood Res 2018; 53(4): 320-324
Published online December 31, 2018 https://doi.org/10.5045/br.2018.53.4.320
Copyright © The Korean Society of Hematology.
Abdolrahim Ahmadi1, Saeid Kaviani1,#*, Marjan Yaghmaie2,3,4,#*, Hossein Pashaiefar2,3,4, Mohammad Ahmadvand2,3,4, Mahdi Jalili2,3,4, Kamran Alimoghaddam2,3,4, Mohammad Eslamijouybari5, and Ardeshir Ghavamzadeh2,3,4
1Department of Hematology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran.
2Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran, Iran.
3Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Tehran, Iran.
4Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran.
5Comprehensive Cancer Research Center, Mazandaran University of Medical Science, Sari, Iran.
Correspondence to:Correspondence to Saeid Kaviani, M.D. Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran, P.O.Box: 14115-331, kavianis@modares.a.ir
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recent studies have devoted much attention to non-protein-coding transcripts in relation to a wide range of malignancies.
Altered expression of
Keywords:
Relative expression of MALAT1 (2−Δct) in CLL and control group using β2m as internal control gene. Increased expression of
a)Clinical stage of CLL patients according to Rai staging system..
Abbreviations: CLL, chronic lymphocytic leukemia; WBC, White blood cells..
Good: 13q14.3 (sole abnormality); intermediate: trisomy 12 and normal karyotype; Poor: 17p13.1 and 11q22.3..
Jun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, Kwai Han Yoo, Chul Won Jung, Dae Sik Kim, Jeong-Ok Lee, Hyeon Seok Eom, Ja Min Byun, Youngil Koh, Sung Soo Yoon, Jin Seok Kim, Jee Hyun Kong, Ho-Young Yhim, Deok-Hwan Yang, Dok Hyun Yoon, Do Hyoung Lim, Won-Sik Lee, Ho-Jin Shin
Blood Res 2021; 56(4): 243-251Nisha Marwah, Manali Satiza, Niti Dalal, Sudhir Atri, Monika Gupta, Sunita Singh, Rajeev Sen
Blood Res 2021; 56(1): 26-30Mesut Göçer, Erdal Kurtoğlu
Blood Res 2020; 55(4): 206-212
Relative expression of MALAT1 (2−Δct) in CLL and control group using β2m as internal control gene. Increased expression of